Reported Reactions

Devices › Test, time, prothrombin

Device brand name · Prothrombin time test

Inratio Pt/Inr Test Strip: medical device reports filed with FDA

166 reports name it, 2014–2014. Manufacturer given most often on reports: Alere San Diego. Product code GJS.

166
device reports naming the brand
0% of all MAUDE reports · about 13 a year
0
reports, 12 months to August 2026
0 in the 12 months before
76.5%
classified as malfunction
92.3% across the product code
1.8%
classified as death, as reported
3 reports · not verified by FDA

166 medical device reports received by FDA name the brand "Inratio Pt/Inr Test Strip" (prothrombin time test); the manufacturer given most often on reports is Alere San Diego; received from January 2014 to December 2014. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (76.5%), injury (21.1%) and death (1.8%); across all test, time, prothrombin reports (product code GJS) death is recorded in 0.2% and malfunction in 92.3%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are incorrect or inadequate test results (50%), low test results (43.4%) and high test results (13.9%). The patient problems coded most often are hemorrhage/blood loss/bleeding, hematuria and bruise/contusion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Inratio Pt/Inr Test Strip was received in the five years to August 2026; the latest was received in December 2014.

Event type and report source

Event type, as classified on the report

Death1.8%3
Injury21.1%35
Malfunction76.5%127
Other0%0
Not given0.6%1

Who filed the report

Manufacturer report100%166
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 26,556 reports carrying product code GJS. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Incorrect or inadequate test results8350%23%
Low test results7243.4%12.9%
High test results2313.9%32.6%
Incorrect, inadequate or imprecise result or readings116.6%23.2%
Improper or incorrect procedure or method21.2%1.1%
Device displays incorrect message10.6%0.6%
False reading from device non-compliance10.6%0%
Insufficient device problem information10.6%0.2%
Low readingsreadings were too low10.6%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Hemorrhage/blood loss/bleeding169.6%
Hematuria63.6%
Bruise/contusion42.4%
Deaththe patient died; cause not stated by this term42.4%
Test result31.8%
Anemialow red blood cells21.2%
Cardiac arrestthe heart stopped21.2%
Painpain, site not specified21.2%
Skin discoloration21.2%
Weakness21.2%
Apnea10.6%
Bacterial infectiona bacterial infection10.6%
Cancer10.6%
Cardiac enzyme elevation10.6%
Chillschills or shivering10.6%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureInratio Pt/Inr Test StripProduct code GJSAll MAUDE reports
Reports16626,55626,136,888
Share of that pool—0.6%0%
Classified as death, per 1,000 reports1829
Classified as injury21.1%6.5%36.2%
Classified as malfunction76.5%92.3%62.3%
Filed by the manufacturer100%99.3%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code GJS

BrandReportsLatest 12 monthsClassified as death
Coaguchek Xs System14,94520.1%
Inratio7,45200.1%
Inratio21,95900.2%
Inratio Pt/Inr Test Strips1,57600.8%
CoaguChek XS PT Test PST474120%
Coaguchek Xs Pt Test34120.3%
Protime Microcoagulation System75000.5%
I-Stat Pt/Inr Cartridge33000%
Dade Innovin19150%
Coaguchek S System2,67400%
Coaguchek Pt Test Strips92300.1%
Triage Cardiac Profiler Kit16800%
Accu-Chek Aviva Test Strips11,07300%
Triage Cardiac Panel 25 Test23301.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Inratio Pt/Inr Test Strip reports

How many FDA reports name Inratio Pt/Inr Test Strip?

166 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (76.5%), injury (21.1%) and death (1.8%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

incorrect or inadequate test results (50%), low test results (43.4%), high test results (13.9%), incorrect, inadequate or imprecise result or readings (6.6%) and improper or incorrect procedure or method (1.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Inratio Pt/Inr Test Strip was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.